Analysis: China case shows war on drug costs in emerging markets

[riky]

Analysis: China case shows war on drug costs in emerging markets

<p><a href="http://news.yahoo.com/analysis-china-case-shows-war-drug-costs-emerging-131100295.html"><img src="http://l1.yimg.com/bt/api/res/1.2/lErodH5TWlc0rf6ZEIuSLQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-07-12T141640Z_2_CBRE96B10MV00_RTROPTP_2_GSK-CHINA.JPG" width="130" height="86" alt="The logo of GlaxoSmithKline is seen on its office building in Shanghai" align="left" title="The logo of GlaxoSmithKline is seen on its office building in Shanghai" border="0" /></a>By Ben Hirschler, Adam Jourdan and Lavinia Mo LONDON/HONG KONG (Reuters) - International drugmakers are under fire in emerging markets as governments crack down on high prices and corporate malpractice, raising a risk to the price premiums global players enjoy over local rivals. China's probe into pricing by 60 firms, including local units of multinationals, and its dramatic charge against GlaxoSmithKline Plc of widespread bribery to boost sales and prices are the latest salvos. ...</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login